Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
The company stated it reached a significant milestone last year.
THC beverages are growing in popularity driven by a shift away from alcohol.
Patients will now be able to access Kanabo’s medical cannabis and CBD products through The GP Service (GPS).
The UK-based CBD brand will out the funds towards streamlining the business.
Canxchange explores how a lack of coherent price indexing for hemp affects the commodity’s prices.
The legalisation of cannabis has been a boon for the financial industry, says new study.
New Frontier Data has released its latest industry report exploring predictions for the year to come.
A new report has projected the market to exceed $310m by 2027.
Canxchange is introducing more transparency, liquidity and efficiency to the growing cannabis market through its new platform.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
